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 2 
Abstract 17 
Xylanases are very often modular enzymes composed of one or more catalytic domains 18 
and a carbohydrate-binding module connected by a flexible linker region. Usually, when these 19 
proteins are processed they lose their carbohydrate-binding capacity. 20 
Here, the role of the linker regions and cellulose- or xylan-binding domains in the 21 
processing of Xys1L from Streptomyces halstedii JM8 and Xyl30L from Streptomyces 22 
avermitilis UAH30 was studied. Xys1 variants with different linker lengths were tested, these 23 
being unable to avoid protein processing. Moreover, several fusion proteins between the Xys1 24 
and Xyl30 domains were obtained and their proteolytic stability was studied.  25 
 We demonstrate that carbohydrate-binding module-processing takes place even in the 26 
complete absence of the linker sequence. We also show that the specific carbohydrate module 27 
determines this cleavage in the proteins studied. 28 
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Introduction 33 
Xylanases (EC 3.2.1.8.) are the most important enzymes responsible for the hydrolysis 34 
of the main hemicellulosic component of plants, namely xylan. They may be used in different 35 
industrial applications, such as in the food industry (juice clarification, fruit maceration, coffee 36 
extraction…), the paper industry (prebleaching, the refining of pulp fibre, the de-inking of 37 
recycled fibres…), the processing of residues (ethanol production) and in animal nutrition 38 
(forage predigestion) [2-4, 9]. 39 
Enzymes with xylanase activity mainly belong to families 10 and 11 of  ß-glycanases 40 
but they have also been identified in families 5, 8, 26 and 43 [9] out of the 118 families 41 
 3 
described to date (http://www.cazy.org/Glycoside-Hydrolases.html). Many of these xylanases 42 
are modular enzymes composed of one or more catalytic domains (CD) and a carbohydrate-43 
binding module (CBM) connected by a flexible linker region (LK) rich in proline, glycine, and 44 
hydroxy amino acids. CBMs may be located either at the N-terminal, the C-terminal, or both. 45 
To date, 59 families of CBMs have been described (http://www.cazy.org/Glycoside-46 
Hydrolases.html). The carbohydrate-binding domain is important for degrading complex 47 
substrates [7]. Nevertheless, many of these xylanases are processed to their CD, and they lose 48 
this degradation capacity.   49 
 An example of these modular xylanase is Xys1 from Streptomyces halstedii JM8 50 
(EMBL AAC4554.1), which belongs to family 10, harbouring a cellulose-binding domain 51 
(CBD) [19]. This protein is produced in Streptomyces halstedii JM8 as a large 45 kDa protein 52 
(Xys1L) that is secreted to the supernatant and processed to a small 33.7 kDa variant (Xys1S) 53 
and its CBD by proteolytic cleavage (Fig. 1). The same processing occurs when the gene is 54 
cloned in other Streptomyces species, such as S. lividans 66 or S. parvulus and both enzymes 55 
are fully active, although Xys1S loses its cellulose-binding capacity [20]. The 3-D structure of 56 
the catalytic domain has been resolved [8].  57 
Another example of a modular xylanase is Xyl30 from Streptomyces avermitilis UAH30 58 
(CECT3339) (NCBI AAD32560.1), composed of a catalytic domain plus a xylan-binding 59 
domain (XBD) [12] (Fig. 1). In this case, the Xyl30 protein is poorly processed in comparison 60 
with Xys1L when expressed in S. lividans 66, and the secreted large version of 42.8 kDa is 61 
much more stable in the supernatants of 6-day-old cultures (Figure 1b). 62 
 Previous work carried out in our laboratory showed that at least five Streptomyces 63 
serine proteases were able to cleave Xys1L in vitro, such as SpB and SpC from S. lividans 66, 64 
and SAM-P20, SAM-P26, and SAM-P45 from S. albogriseolus. This processing was almost 65 
completely inhibited when the serine protease inhibitor slpI gene from S. lividans was co-66 
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expressed with the xylanase xysA gene in S. lividans. In contrast, none of these proteases was 67 
able to process Xyl30 in vitro [10]. 68 
Preliminary studies performed with the xylanase Xys1 in poultry feed have been carried 69 
in collaboration with NOREL SA (a Spanish company dedicated animal nutrition), showing the 70 
ability of this enzyme to improve digestibility in animals and to increase their weight to levels 71 
even better than the commercial enzymes used for this purpose (data not shown). One 72 
improvement in the Xys1L enzyme would be to prevent CBD domain processing in order to 73 
increase the binding of the enzyme to forage. Thus, here we made several attempts to eliminate 74 
the cleavage of Xys1L. First, we constructed different xysA variants (the gene that encodes 75 
Xys1) with progressive deletions in the linker region sequence, and second we constructed 76 
chimerical proteins between the CDs and the CBD or XBD of Xys1 and Xyl30 respectively.  77 
 The results showed that the processing of Xys1L is not linker region length-specific and 78 
therefore that protease activity depends more on the structure of the CD domain and, mainly in 79 
the sequences present in the carbohydrate-binding domain (CBD or XBD). 80 
 81 
Materials and Methods 82 
Bacterial strains and DNA manipulation 83 
Escherichia coli strain DH5 [11] was grown in Luria –Bertani (LB) liquid broth or on 84 
LB agar. R2YE and the MSA sporulation medium were used for S. lividans JI66. Liquid 85 
cultures of S. lividans JI66 were performed in 10 ml of YES medium [20] supplemented with 86 
1% xylose in 100-ml three-baffled flasks. 10
6
 spores ml
-1
 were used as inoculum.  Cultures 87 
were carried out at 30º C and 200 rpm for four days. When necessary, the medium was 88 
supplemented with antibiotics (100 µg ml
-1
 for ampicillin for E. coli, 50 µg ml
-1 
for kanamycin 89 
for E. coli or S. lividans JI66). DNA manipulations of E. coli and Streptomyces were done as 90 
indicated by Sambrook et al. [22] and Hopwood et al. [13]. 91 
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Plasmid constructions 92 
All oligonucleotide sequences used in this work are shown in Table I. The xysA gene 93 
variants were generated by PCR using a common reverse oligonucleotide including an XbaI 94 
site (LK3’) and several forward oligonucleotides adding an XhoI site (LKM0, LKM1, LKM2, 95 
LKM3, LKM4, and LKM5). The PCR fragments were cloned in the XhoI/XbaI sites of the E. 96 
coli pSK
+
 plasmid, obtaining pSHA2vo, v1, v2, v3, v4 and v5. Then, all amplifications were 97 
cloned into the E. coli/Streptomyces shuttle vector pN702GEM3 [10] in a triple ligation to 98 
construct the xysA derivatives: HindIII/BglII fragment from pN702GEM3 + BglII/XhoI 99 
fragment from pXHis1 [1] + XhoI/HindIII fragment from the corresponding pSHA2 (v0-v5). In 100 
these constructions, all modifications were under the control of xysA promoter and flanked by 101 
mmrt and fdt transcriptional terminators, affording the different xysA plasmid versions 102 
(pVR055 to pVR060) (Fig. 2a). 103 
Chimerical genes between xysA and xyl30 were generated using the SalI restriction enzyme site 104 
present at the end of the CD coding region of both genes. The chimerical genes were obtained 105 
in several steps (not detailed) and cloned into the pN702GEM3 vector, affording plasmid 106 
pNX1/X30-SalI (273 amino acids Xys1 CD + 76 amino acids Xyl30 CD + 88 amino acids 107 
Xyl30 XBD) and plasmid pNX30/X1-SalI (272 Xyl30 CD amino acids + 74 Xys1 CD amino 108 
acids + 108 amino acids Xys1 CBD).  109 
A new set of recombinant genes between xyl30 and xysA was obtained as follows. The 110 
CD module of Xyl30 was amplified with primers MRG24 and MRG25 (Table I), including the 111 
NdeI and XhoI sites respectively. The PCR fragment thus obtained was cloned by replacing the 112 
xysA CD module in plasmid pVR055, yielding pNX30/X1.A (containing the whole CBD xysA 113 
module with the linker region), and in plasmid pVR059 obtaining pNX30/X1.B (containing the 114 
v4 CBD xysA module variant without the linker region). Additionally, the XBD domain of 115 
Xyl30 was amplified with and without its linker region, using the primers MRG21 and MRG22 116 
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or MRG20 and MRG22, respectively (Table II). The corresponding PCR fragments obtained 117 
were cloned into plasmid pVR055, replacing the CDB plus the linker region of xysA gene by 118 
Xyl30 XBD (with and without the linker), obtaining plasmids pNX1/X30.A and pNX1/X30.B.  119 
The entire DNA xysA variant constructs and xysA-xyl30 fusions were sequenced in both 120 
strands using a Perkin Elmer ABI Prism 377 DNA sequencer. The plasmids obtained (Table II) 121 
were transformed in S. lividans JI66 and protein production was analyzed. Manipulation was 122 
accomplished with the Gene Construction Kit (GCK, Textco)). 123 
Protein analysis 124 
Protein proteolytic events were assessed by SDS–PAGE (15% acrylamide in a 125 
MiniProtean II system, BioRad). Low-molecular weight standards from Bio-Rad were used as 126 
size markers. Coomassie blue R was used for protein staining. Protein was quantified by the 127 
method of Peterson [18] with bovine serum albumin as the standard. 128 
 Immunodetection of Xys1 was performed with anti-Xys1 antibodies on proteins 129 
transferred to Immobilon-P (Millipore), with anti-rabbit alkaline-phosphatase-conjugated 130 
antibodies (Promega) as secondary antibodies.  131 
 The amino-terminal amino acid sequence was determined in proteins separated by SDS-132 
PAGE, blotted onto Immobilon-P (Millipore) membranes, and cut off. The amino terminus was 133 
sequenced with an Applied Biosystems 470A Protein Sequenator. 134 
Enzyme activity assays.  135 
 The dinitrosalicylic acid (DNS) method, using xylose as standard [5, 6], was used to 136 
measure xylanase activity in culture supernatants. One unit of enzyme activity was defined as 137 
the amount of enzyme required to release 1 µmol of reducing sugars (expressed as xylose 138 
equivalents) in one minute. All data shown are averages of at least three different experiments. 139 
Xylan and cellulose binding assays 140 
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The ability of the proteins to bind cellulose or xylan was studied by incubating the 141 
supernatant containing the proteins for 2 hours at room temperature with 4 % avicel (Merck) or 142 
with 4 % insoluble oatspelt xylan (Sigma) respectively. The mix was centrifuged for 5 minutes 143 
at 13000 rpm and the insoluble fraction was washed twice with water. Following this, 1x SDS-144 
loading buffer was added to the insoluble fraction and this solution was boiled for 5 minutes to 145 
elute the retained protein. The proteins present in each fraction were analyzed by SDS-PAGE. 146 
 147 
Results 148 
Xys1 processing is not dependent on specific linker size 149 
The processing of Xys1L to produce Xys1S was mainly observed in aged cultures 150 
(older than 48 h) and Xys1L xylanase cleavage occurred after the D362 residue in S. lividans 151 
[21]. This residue forms part of a linker of 15 amino acids that separates the catalytic domain 152 
and the CBD. To test the importance of linker length in protein processing, several variants 153 
were obtained by progressive deletion of this region (see Materials and Methods). As a result of 154 
the cloning process, an extra E residue was present in all the constructs (in bold in Figure 2a) 155 
but this did not affect the proteolytic process, as tested in the v0 variant (Fig. 2b). The v1 156 
variant lacked the first 8 amino acids of the linker region. Variant v2 had a deletion of the first 157 
12 aa and contained only the last 3 amino acids, and v3 was a version lacking the whole linker 158 
region (15 aa). Additionally, we obtained a v4 variant without the 15 aa of the linker plus the 159 
first two amino acids of the CBD domain, and a v5 variant without the linker plus 10 amino 160 
acids of the CDB, involving the loss of C365, which forms a disulphide bond with C458 [21].  161 
The different plasmids (pVR055(v0) to pVR060(v5)) were introduced into S. lividans 162 
and liquid cultures were performed and analysed after 72 h of culture. As shown in Figure 2b, 163 
all the Xys1 protein variants generated were processed. Proteins with deletions in the linker 164 
region (v1, v2, and v3) underwent a proteolytic event similar to that observed in the wild-type 165 
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protein (v0). When the first two amino acids (v4) or the first 10 amino acids (v5) of CBD were 166 
also eliminated, all the Xys1L protein was immediately processed to Xys1S, which was 167 
accumulated in the supernatant. The use of anti–Xys1 antibodies revealed that the Xys1L form 168 
was not detected in the v4 and v5 variants in 24-h-old cultures (Fig. 2c). Nevertheless, the CBD 169 
was detected by the antibodies in v4 but not in v5 (Fig. 2c), indicating the stability of the CBD 170 
in v4 and the instability of this domain in the v5 variant, presumably due to the lack of the 171 
disulfide bond between C365 and C458. 172 
 173 
Xys1 and Xyl30 protein fusions are processed in different ways depending of the modules 174 
used.  175 
Significantly different processing rates of the xylanase Xys1 (X1) and Xyl30 (X30) 176 
proteins expressed in S. lividans were observed under our culture conditions. While X1 was 177 
almost totally processed after 6 days of culture, X30 had not undergone much processing at this 178 
culture time (Fig. 1b). Blast analysis indicated that the catalytic domains of both proteins 179 
shared 58 % identity and 69 % similarity, whereas the carbohydrate binding domains were 180 
quite different (23 % identity and 32 % similarity). In fact, X1 has a CBD (family CBM-2) 181 
while X30 has an XBD (family CBM-13). Additionally, the linker region that separates both 182 
domains was shorter in X30 than in X1 (Fig. 1a). 183 
With the final aim of obtaining an X1 protein more resistant to proteolytic cleavage, we 184 
studied the importance of the linker region and CBM of both proteins in processing. Different 185 
fusions between the genes encoding X30 and X1 were generated by interchanging the DNA 186 
sequences that encode these regions. 187 
First, we used a SalI restriction site present in the same frame in both genes and situated 188 
at the carboxy terminus of the CD coding sequence (Fig. 3a). The F1 and F2 fusions were 189 
obtained in plasmids pNX1/NX30-SalI and pNX30/NX1-SalI respectively, as described in 190 
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Materials and Methods. S. lividans cells harbouring these plasmids were grown in order to 191 
analyze the stability of the proteins produced after 72 hours of culture. The cultures carrying F1 192 
accumulated a protein of only 17 kDa but no protein bands of the expected size (45 kDa) were 193 
observed (Fig. 3b upper panel). Moreover, neither the L nor the S forms of the chimerical F1 194 
xylanase were detected, even when anti-Xys1 was used in Western-blot assays (Fig. 3b middle 195 
panel). Also, no xylanase activity was detected in these cultures (Fig. 3b lower panel). The N-196 
terminal sequence (GDPXXE) of the P17 protein corresponded to the XBD of X30 and was 197 
specifically retained by oatspelt xylan but not by avicel when carbohydrate-binding 198 
experiments were performed (Fig. 3c). This result showed that this P17 was a functional xylan-199 
binding module. Production of the L-form by F1 was detected in 1-day culture supernatants 200 
with only anti-Xys1, but not with Coomasie Blue (Fig. 3c). This demonstrated that the F1 201 
protein was produced but that it was quickly processed to its CD-X1/X30 and XBD domains. In 202 
this case, the fusion CD was extremely unstable and was degraded after processing. However, 203 
the XBD, not recognised by anti-Xys1 antibodies, was very stable and accumulated in the 204 
supernatant.  205 
The F2 protein, which has the catalytic domain mainly from X30 and the carboxy 206 
terminus of the CD, the linker region, and the CBD of X1, was accumulated in the supernatant 207 
and underwent a processing similar to X1 and to a much greater extent than that observed for 208 
X30 after 3 days of culture (Fig. 3b). Both the L and S forms were detected with anti-Xys1, as 209 
was the processed CBD. Nevertheless, the enzyme activity of this F2 fusion was about 65 % of 210 
the original activity (X1 and X30), showing that the chimerical X30/X1 catalytic domain was 211 
less active (Fig. 3b).  212 
More precise fusion proteins were generated by interchanging the carbohydrate modules 213 
immediately after the last CD amino acid of X1 and X30, affording the F3 and F4 protein 214 
variants, as described in Materials and Methods. Two versions were generated for each protein: 215 
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one with the linker region and another without it: versions A and B respectively (Fig. 4a). S. 216 
lividans transformed with the different plasmids was grown in liquid medium and the 217 
supernatants were analyzed in SDS-PAGE and detected with Coomasie Blue or anti-Xys1.  218 
Analysis of 72-h-old supernatants revealed that both F3 fusion proteins were mainly 219 
accumulated in their S form (Fig. 4b lower panel), while no accumulation of the L form was 220 
observed at this time. Anti-Xys1 antibodies, used on supernatants of 1-day-old cultures, 221 
allowed us to detect the L form and a large number of degradation bands between the L and S 222 
sizes (Fig. 4b upper panel). This result suggested an imprecise cut in the fusion proteins and 223 
their XBD degradation that were independent of the presence or absence of the X30 linker 224 
region, finally accumulating the S form (3-day-old cultures) (Fig. 4b lower panel). A different 225 
type of behaviour was observed for both F4 fusions. Thus, when the 3-day-old culture 226 
supernatants were analyzed a processing similar to that undergone by the original X1 was 227 
obtained for the fusion F4-A, the L and S forms being observed (Fig. 4c lower panel). 228 
However, the F4-B fusion, which did not have any standard linker region between either 229 
domain, was processed completely and only the S form was accumulated at this culture time. 230 
The use of anti–Xys1 antibodies on supernatants from 1-day-old cultures allowed us to detect 231 
the L form in both fusions, and no protein degradation bands, as in the case of the F3 fusions, 232 
were observed, pointing to a precise site of proteolysis. Again, this cleavage was not dependent 233 
on the amino acids present in the linker region and these F4 fusions permitted us to obtain 234 
processed forms of the X30 protein (Fig. 4c lower panel). 235 
 236 
Discussion 237 
The broad potential applications of xylanases in industrial processes encompass all three 238 
sectors of the industrial markets (food, feed, and technical). The discovery of new enzymes 239 
(such as extremophilic xylanases) and the basic research carried out to improve the 240 
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characteristics of already described xylanases is currently an active field of research. Thus, the 241 
United States Patents and Trademark Office (http://www.uspto.gov/) lists 468 patents referring 242 
to xylanases since 2001 [9] 243 
As stated above, the elimination of the proteolytic cleavage that occurs in the linker 244 
region separating the catalytic domain from the carbohydrate-binding module would be useful 245 
for certain applications of xylanase, such as in animal feed, where the digestion of complex 246 
substrates is necessary. The collection of chimerical enzymes combining the catalytic and 247 
sugar-binding domains from different organisms is another way to eliminate this processing 248 
and improve the properties of the enzymes. Some examples that support this observation are 249 
that the fusion of family 2b of the carbohydrate-binding module from S. thermoviolaceus STX-250 
II to the carboxyl-terminus of XynB from Thermotoga maritima, (XynB-CBM2b) increases the 251 
catalytic activity of the original enzyme against soluble xylan [14] and that the addition of a 252 
family 6 CBM to Bacillus halodurans xylanase enhances activity against insoluble xylan [17].  253 
CBM modules are usually joined to the catalytic domain by a flexible linker region that permits 254 
the proper packaging of both domains and that could play a role in protein stability, as occurs 255 
with XynAS27 from Streptomyces sp. S27 [15]. The linker region has been used to construct 256 
bifunctional fusions such as ß-glucanase and xylanase [16].  257 
Here we studied the role of the linker regions and substrate-binding modules of Xys1L 258 
(X1-L) and Xyl30L (X30-L) in their processing. The initial goals of this study were to improve 259 
basic knowledge about this event and, if possible, to obtain unprocessed versions of Xys1L 260 
protein, which could improve its effectiveness in animal feed.  261 
The deletion of different numbers of amino acids in the linker region (LK) of X1-L was 262 
expected to originate unprocessed forms of this xylanase. However, not only did the different 263 
deletions of this LK region fail to prevent the processing of the protein (vo-v3) but,  also, 264 
deletions that eliminated the entire linker region and the first two or ten amino acids of the 265 
 12 
CBD (v4, and v5 respectively) originated proteins that were processed immediately. The 266 
accumulation of the X1-S form was observed in these v4 and v5 deletions, while it was very 267 
difficult to detect the large X1L protein in young cultures (24 h old). Therefore, CD and/or 268 
CDB, and not the LK, must determine the proteolytic event that occurs in this xylanase. This 269 
result was corroborated by obtaining fusion proteins in which the CD of X30, a xylanase that is 270 
scarcely processed, was linked to the CBD of X1 with or without X1-LK (Fusions F4A and 271 
F4B respectively). In both constructions, the proper processing of both domains occurred in a 272 
similar way to the original X1. Thus, the linker region is not necessary for the proteolytic 273 
processing of the L form of X1.  274 
We also observed that the first cysteine (C365) of the X1-CBD was essential for the 275 
correct conformation of the binding module, because the disulfide bond that this residue 276 
establishes with C458 was eliminated. Consequently, the binding domain of v5 is degraded in 277 
the supernatant while this degradation does not occur when C365 is present (v4).  278 
The presence of an in-frame SalI restriction site in the genes that encode X1 and X30 279 
(upstream from the sequences that encode V274 and V273 respectively) facilitated the 280 
collection of CD hybrids of the X1 and X30 peptides.  Both proteins shared 66 % identity and 281 
72 % similarity in this region (from V274 to L347 in X1 and from V273 to L342 in X30). 282 
However, although the similarity between the CDs of both proteins in the interchanged region 283 
was very high (SalI peptides) and the xylanase processing of the chimerical proteins was 284 
expected to be similar, the instability of the hybrid CD of one of the fusions (F1), which carried 285 
the N-terminus part of the CD of Xys1 and the SalI carboxyl part of X30, suggests the 286 
importance of the carboxyl part of the X1-CD in the stability of this domain. This result was 287 
corroborated in the CD of other fusions carried out (F2) harbouring the N-terminus part of the 288 
CD of X30 and the SalI carboxyl part of X1 that was stable and was processed in a similar way 289 
to the original X1. The importance of the carboxy SalI fragment of Xys1CD stabilization was 290 
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again corroborated in the fusion of the entire X1-CD with the XBD of X30, with or without the 291 
X30 linker region (F3A and F3B), where an accumulation of the complete CD was observed (S 292 
form). Interestingly, no specific processing from F3L to yield F3S was observed, and a non-293 
specific proteolytic degradation not observed from F4L to yield F4S was detected. This 294 
indicates that degradation was not dependent on the presence or absence of the linker region 295 
(F3A and F3B respectively).  296 
In conclusion, although it is generally believed that CBMs processing mainly depends 297 
on the preceding linker sequence, here we demonstrate that this assumption should not be taken 298 
for granted because, at least in the proteins studied, it occurs even in the complete absence of 299 
this linker sequence. We also show that the CBD of Xys1 is able to determine the cleavage in 300 
the Xyl30 protein, which initially is barely processed, opening new possibilities for the 301 
generation of modified proteins (Figure 5).  302 
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Figure legends 369 
Figure 1: a) Clustal W alignment of Xys1 and Xyl30 mature L-form proteins. The catalytic 370 
domains (CD) and carbohydrate-binding modules (CBD and XBD respectively) are marked in 371 
a box; the linker region (LK) is between both domains. SalI: denotes the SalI position in the 372 
corresponding coding genes. b) Schematic representation of Xys1 and Xyl30 proteolytic 373 
processing of their CDs and CBM modules (upper part) and SDS-PAGE protein gels stained 374 
with Coomasie blue showing the proteins in 10 µl of culture supernatant after 3 and 6 days of 375 
culture (lanes 3d and 6d respectively) (lower part). (L: L-form; S: S-form). 376 
Figure 2: a) Schematic representation (upper part) and peptide sequences of the different 377 
variants of Xys1 obtained in this work: pVR055(v0) to pVR060 (v5) (lower part). All the 378 
variants contain an extra E347 amino acid in the junction region of the construct (in bold). The 379 
last amino acid of the linker region corresponds to D362. C365, which is important for the 380 
stability of CBD, is also marked in bold. b) SDS-PAGE protein gel stained with Coomasie blue 381 
showing the processing of the protein variants in 10 µl of culture supernatant after 3 days 382 
culture. c) SDS-PAGE protein gel stained with Coomasie blue (left) and Western blot with 383 
anti-Xys1 (right) showing the processing of the protein variants (v0, v3, v4, and v5) in 10 µl of 384 
culture supernatant after 1 day of culture. 385 
Figure 3: a) Schematic representation of the different domains of the F1 and F2 protein fusions 386 
from Xys1 (X1) and Xyl30 (X30). They were constructed using the SalI restriction enzyme site 387 
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present in-frame in both coding genes. b) SDS-PAGE protein gel stained with Coomasie blue 388 
(upper part), Western blot with anti-Xys1 (middle part), and xylanase activity (lower part) 389 
showing the processing of the protein fusions (F1 and F2) in 10 µl of culture supernatant after 3 390 
days of culture together with their enzyme activities. c) Retention assay in xylan (left) or avicel 391 
(right) of the protein accumulated in a 3-day supernatant of the F1 fusion-producing strain (S: 392 
10 µl of supernatant, NR: non-retained fraction; R; retained fraction). d) SDS-PAGE protein 393 
gel stained with Coomasie blue (left) and Western blot with anti-Xys1 (right), showing the 394 
production of the L form in X1 and F1 in 10 µl of culture supernatant after 1 day of culture. (L: 395 
L-form; S: S-form). 396 
Figure 4: a) Schematic representation of the different F3 and F4 fusions between Xys1 (X1) 397 
and Xyl30 (X30) CDs and CBMs. A-versions have the corresponding linker region and B-398 
versions do not. b) Western blot with anti-Xys1 after 1 day of culture (upper part), and SDS-399 
PAGE protein gel stained with Coomasie blue of a 3-day culture (lower part) showing the 400 
processing of the  protein fusions (F3A and F3B) in 10 µl of culture supernatant as compared to 401 
X1. b) Western blot with anti-Xys1 after 1 day culture (upper part), and SDS-PAGE protein gel 402 
stained with Coomasie blue of a 3-day culture (lower part) showing the processing of the 403 
protein fusions (F4A and F4B) in 10 µl of culture supernatant compared to X1 and X30. (L: L-404 
form; S: S-form) 405 
Figure 5: Protein scheme of the different forms (L and S) and CBMs produced by the 406 
constructs studied (X1, X30, F1, F2, F3, and F4). The accumulated proteins in the supernatants 407 
are filled with grey. ( : protein degradation). 408 
 409 
 410 
 411 
 412 
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Tables 413 
Table I – Primers used in this work 414 
Primers Sequence (5´-3´) Function  
LK3’ ATTATTTCTAGAGTCAGGAAGCGGTGCAGGCACCC Amplification of LK + CBD of xysA (reverse) 
LKM0 ATTATTCTCGAGGGCGGTTCCGGCGGAGGCGGTG Amplification of LK + CBD of xysA (forward) 
LKM1 ATTATTCTCGAGGACGGCGGGGAGGGCGGCGAC Deletion 1 of LK of xysA (forward): v1 
LKM2 ATTATTCTCGAGGGCGGCGACGGCGCCTGCACG Deletion 2 of LK of xysA (forward): v2 
LKM3 ATTATTCTCGAGGGCGCCTGCACGGCGACGTAC Deletion 3 of LK of xysA (forward): v3 
LKM4 ATTATTCTCGAGTGCACGGCGACGTACACCCGGAC Deletion 4 of LK  + CDB of xysA (forward): v4 
LKM5 ATTATTCTCGAGTCGACGTGGAACGGCGGATACAACG Deletion 5 of LK  + CDB of xysA (forward): v5 
MRG20 TTTTTTCTCGAGGGCGACCCCGACCCGGAGCCCG 
Amplification of the XBD module of Xyl30 without 
linker. Forward (includes an XhoI site, underlined) 
MRG21 TTTTTTCTCGAGAACGCCGGCGACGGCGGCGGTGG 
Amplification of XBD module of Xyl30. Forward 
(includes an XhoI site, underlined) 
MRG22 ATTATTTCTAGAGTCAGACGCCACTTCTGTTGTCGCCAC 
Amplification of the XBD module of Xyl30. Reverse 
(includes an XbaI site, underlined) 
MRG24 TTTTTTCATATGGGCTTTCACGCCCTCCCCAGATC 
Amplification of the CD module of Xyl30. Forward 
(includes an NdeI site, underlined) 
MRG25 ATTATTCTCGAGGAGGGCGTTCAGCACGGCGTTGTAC 
Amplification of the CD module of Xyl30. Reverse 
(includes a XhoI site, underlined)  
 415 
Table II  - Plasmids used in this work 416 
Vector Characteristics Reference 
pXHis1 pIJ2925 derivative containing the  xysA gene and promotor  [1] 
pSK+  E. coli plasmid Amp resistance, lac promoter, bla Stratagene 
pSHA2v0 pSK+ derivative containing  the xysA gene v0 (wt: full linker sequence) This work 
pSHA2v1 pSK+  derivative containing  the  xysA gene v1 (deletion 1 of linker sequence) This work 
pSHA2v2 pSK+  derivative containing  the  xysA gene v2 (deletion 2 of linker sequence) This work 
pSHA2v3 pSK+  derivative containing  the  xysA gene v3 (deletion 3 of linker sequence) This work 
pSHA2v4  
pSK+  derivative containing  the xysA gene v4 (deletion 4 of  the  linker sequence + 2 aa 
of CBD) 
This work 
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pSHA2v5 
pSK+  derivative containing the xysA gene v5 (deletion 5 of linker sequence + 10 aa of 
CBD including cysteine 365) 
This work 
pN702GEM3 E. coli–Streptomyces shuttle vector; Neo/Kan resistance  [10] 
pVR055 pN702GEM3 derivative containing  the  xysA gene v0 (wt: full linker sequence)  This work 
pVR056 pN702GEM3 derivative containing  the  xysA gene v1 (deletion 1 of linker sequence)  This work 
pVR057 pN702GEM3 derivative containing  the xysA gene v2 (deletion 2 of linker sequence) This work 
pVR058 pN702GEM3 derivative containing  the  xysA gene v3 (deletion 3 of linker sequence) This work 
pVR059 
pN702GEM3 derivative containing the  xysA gene v4 (deletion 4 of linker sequence + 2 
aas of CBD) 
This work 
pVR060 
pN702GEM3 derivative containing  the  xysA gene v5 (deletion 5 of linker sequence + 
10 aas of CBD including the first cysteine) 
This work 
pNX1/X30-SalI 
pN702GEM3 derivative containing fusion of   the xysA and xyl30 catalytic domains and 
XBD  (using SalI restriction  site)  F1 
This work 
pNX30/X1-SalI 
pN702GEM3 derivative containing fusion of xyl30 and xysA catalytic domains and 
XBD  (using SalI restriction  site)  F2 
This work 
pNX1/X30-A 
pN702GEM3 derivative containing the fusion of the xysA catalytic domain and the 
xyl30 linker sequence and XBD    F3-A 
This work 
pNX1/X30-B 
pN702GEM3 derivative containing the fusion the of xysA catalytic domain and xyl30 
XBD  (without  linker sequence)  F3-B 
This work 
pNX30/X1-A 
pN702GEM3 derivative containing fusion of xyl30 catalytic domain and xysA v0 linker 
sequence and CBD  F4-A 
This work 
pNX30/X1-B 
pN702GEM3 derivative containing the fusion of the xyl30 catalytic domain and xysA 
CBD v4 (deletion 4 of linker sequence)  F4-B 
This work 
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